Page last updated: 2024-11-05

vesnarinone and Chemical and Drug Induced Liver Injury

vesnarinone has been researched along with Chemical and Drug Induced Liver Injury in 2 studies

Chemical and Drug Induced Liver Injury: A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment.

Research Excerpts

ExcerptRelevanceReference
"Vesnarinone is an experimental drug which is known to inhibit TNF alpha release."1.30Vesnarinone inhibits immune-mediated but not Fas (CD95) agonist-mediated hepatic injury. ( Baumann, H; Jacob, CO; Kambayashi, T; Lazarus, DD; Strassmann, G; Yato-Kioka, M, 1997)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fourches, D1
Barnes, JC1
Day, NC1
Bradley, P1
Reed, JZ1
Tropsha, A1
Lazarus, DD1
Kambayashi, T1
Yato-Kioka, M1
Baumann, H1
Jacob, CO1
Strassmann, G1

Other Studies

2 other studies available for vesnarinone and Chemical and Drug Induced Liver Injury

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLI

2010
Vesnarinone inhibits immune-mediated but not Fas (CD95) agonist-mediated hepatic injury.
    International journal of immunopharmacology, 1997, Volume: 19, Issue:1

    Topics: Acute-Phase Reaction; Animals; Antibodies, Monoclonal; Autoimmune Diseases; Chemical and Drug Induce

1997